Target intelligence / Profile preview

ADP-ribosyltransferase 4 (Dombrock blood group carrier) (ART4)

Target
ART4
Molecular classification
Enzyme family member, Membrane protein, Blood group antigen, Cluster of differentiation
01

Overview

ADP-ribosyltransferase 4 (ART4), also known as Dombrock blood group carrier (CD297), is a glycosylphosphatidylinositol (GPI)-anchored membrane protein predominantly expressed on human erythrocytes and certain leukocytes. ART4 belongs to the ecto-ADP-ribosyltransferase family, containing a mono-ADP-ribosylation motif, but it lacks clear enzymatic activity in humans—the catalytically essential "active site" motif is altered and no ADP-ribosyltransferase function has been demonstrated experimentally. Instead, ART4 serves as the molecular carrier of Dombrock blood group antigens, with its allelic variation being significant for transfusion medicine due to the risk of adverse immune reactions. ART4 has also been implicated in membrane microdomain organization relevant to erythrocyte invasion by *Plasmodium falciparum*, suggesting possible roles in host–pathogen interactions and malaria susceptibility. Its physiological roles likely center on membrane protein structure, antigenic specificity for blood typing, and as a minor participant in cell signaling rather than a direct drug target.

Other names
Ecto-ADP-ribosyltransferase 4ART4CD297Dombrock blood group carrier moleculeDOK1ARTC4Do glycoproteinMono(ADP-ribosyl)transferase 4NAD(+)--protein-arginine ADP-ribosyltransferase 4NAD(P)(+)--arginine ADP-ribosyltransferase 4Dombrock glycoprotein
02

Biological functions

Blood group antigenMembrane organizationCell–cell signalingImmune response and host–pathogen interactions
03

Disease associations

Transfusion reactionsMalaria susceptibilityBlood group incompatibilitySickle cell disease
04

Safety considerations

Transfusion-related adverse reactionsHemolytic disease
05

Biomarkers

Blood group typing for transfusion compatibilityGenetic variants for malaria risk stratification

Beyond the preview

Go deeper on ADP-ribosyltransferase 4 (Dombrock blood group carrier) (ART4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADP-ribosyltransferase 4 (Dombrock blood group carrier) (ART4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call